Results 11 to 20 of about 1,090 (156)
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London [PDF]
EyeThis is a summary of some of the panel and round table discussions held under the auspices of the European Group on Graves’ Orbitopathy (EUGOGO) GlobalTED Forum at Imperial College London in September 2025 to identify unmet needs, explore future ...
Mario Salvi, Vickie Lee, Colin Dayan
exaly +6 more sources
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) [PDF]
British Journal of Ophthalmology, 2023 BackgroundGraves’ orbitopathy (GO) is subject to epidemiological and care-related changes. Aim of the survey was to identify trends in presentation of GO to the European Group On Graves’ Orbitopathy (EUGOGO) tertiary referral centres and initial management over time.MethodsProspective observational multicentre study. All new referrals with diagnosis of
Anna Schuh +36 more
core +13 more sources
Zhongshan Daxue xuebao. Yixue kexue ban, 2018 【目的】分析甲状腺相关眼病（GO）以欧洲甲状腺相关眼眶病专家组（EUGOGO）标准分级的临床特 征。【方法】回顾性收集2010年1月-2016年12月于中山大学孙逸仙纪念医院内分泌与眼科明确诊断为GO的 110例病例，记录其病史、眼部检查，分别按照EUGOGO标准、NOSPECS标准进行GO严重程度的分级，按照临床 活动度评分（CAS）进行GO炎症活动度的分级，并对这些指标进行综合性分析。【结果】本研究共收集110例患 者211眼。患者年龄平均47.4（S=12.8）岁，其中具有吸烟史27例 ...
范淑贤 +4 more
doaj +2 more sources
Journal of Ophthalmology, 2021 Purpose. The intravenous glucocorticoid (iv GC) represents the mainstay of therapy for Graves’ ophthalmopathy (GO), but uncertainty remains concerning the optimal regimen.
Jing Chen, Nuo Xu, Huilan Sun, Gang Chen
doaj +2 more sources
Twentieth EUGOGO Anniversary Symposium [PDF]
European Thyroid Journal, 2020 The European Group on Graves’ Orbitopathy (EUGOGO) organized a highly successful international 20th anniversary meeting on November 7–9, 2019, in the beautiful city of Pisa, Italy. More than 200 experts and key opinion leaders in the field of Graves’ orbitopathy (GO) or thyroid eye disease and thyroid autoimmunity gathered in Tuscany to discuss the ...
Kahaly G. J., Marcocci C.
openaire +4 more sources
The Clinical Features of Graves’ Orbitopathy with Elevated Intraocular Pressure
Journal of Ophthalmology, 2021 Background. To investigate the clinical characteristics of Graves’ orbitopathy (GO) with elevated intraocular pressure (IOP) using the European Group of Graves’ Orbitopathy (EUGOGO) system. Methods.
Shu-Xian Fan +8 more
doaj +2 more sources
Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients [PDF]
Frontiers in Endocrinology, 2019 Background: Quality of life (QoL) studies in patients with mild to moderate Graves' orbitopathy (GO) are scarce.Methods: The original GO-QoL questionnaire was translated to Portuguese and administered to 323 patients with Graves' disease.
Danilo Villagelin +8 more
doaj +3 more sources
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey [PDF]
British Journal of Ophthalmology, 2006 This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe.Forty seven patients with DON presented to seven European centres during one year. Local protocols for thyroid status, ophthalmic examination and further investigation were used.
MCKEAG, D. +21 more
openaire +4 more sources
Treatment of Graves' ophthalmopathy
Клиническая и экспериментальная тиреоидология, 2010 Graves' ophthalmopathy is one of most frequent extrathyroid manifestation of autoimmune thyroid diseases. In 3–5% cases it has severe progress and requires specific therapy.
doaj +2 more sources